(Q53257181)

English

Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.

scientific article published on 5 March 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

10

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

author name string

Ji Yeon Seo

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

Won Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

Jee Hye Kwon

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

Eun Hyo Jin

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

Su Jong Yu

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

Hwi Young Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

Yong Jin Jung

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

Donghee Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

Yoon Jun Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

Hyo-Suk Lee

11

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

publication date

5 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

Liver International

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

33

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

884-893

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

A simple approach to noninvasively identifying significant fibrosis in chronic hepatitis C patients in clinical practice.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Complete blood count reflects the degree of oesophageal varices and liver fibrosis in virus-related chronic liver disease patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Pre-operative predictors of post-hepatectomy recurrence of hepatocellular carcinoma: can we predict earlier?

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B?

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Non-invasive evaluation of liver fibrosis using transient elastography

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Performance of transient elastography for the staging of liver fibrosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Liver stiffness measurement by magnetic resonance elastography is not associated with developing hepatocellular carcinoma in subjects with compensated cirrhosis.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan®).

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12132

21 January 2018

Identifiers

10.1111/LIV.12132

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/23461618

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53257181&oldid=1241737736"